[Efficacy of multidrug therapy in treatment of paucibacillary leprosy patients--preliminary results].
The efficaciousness evaluation of the polychemotherapics regimens recommended by WHO to the hansenian paucibacillary patients, is carried out mainly by the suitable follow up of patients after therapeutic discharge. The criterion for inclusion of patients as paucibacillary ones is another point of importance. The authors based on the follow up of 66 patients that completed treatment and in the absence of relapses until the moment, advise that together with the clinical classification it should be considered factors like: the Mitsuda test, the number of lesions and the bacilloscopy result.
Avelleira
J C
JC
Hospital Estadual de Curupaiti, Rio de Janeiro, Brasil.
Marques
A B
AB
Viana
F R
FR
de Andrade
V L
VL
D004334:Drug Administration Schedule; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007916:Lepromin / Q000276:immunology; D007918:Leprosy / Q000188:drug therapy* / Q000276:immunology / Q000473:pathology; D012008:Recurrence; D012293:Rifampin / Q000008:administration & dosage; D013450:Sulfones / Q000008:administration & dosage
D013450:Sulfones; D007916:Lepromin; D012293:Rifampin
Eficácia da MDT no tratamento de pacientes hansenianos paucibacilares--resultados preliminares.